Group Leader, Milner Therapeutics Institute
Namshik Han aims to develop new Artificial Intelligence approaches and to facilitate access of partner pharma/biotech companies to cutting-edge computational technology fulfilling the global mission of identifying new or better therapies from the analysis of biomedical big data. Learn more.
Research AreasTherapeutic target discovery across disease
Personalised medicine
Drug efficacy and safety
Drug positioning/ repositioning
Biomarker discovery
|
TechniquesArtifical Intelligence
Computational biology
Multi-omics analysis
Network analysis
NLP and text mining
|
Areas for CollaborationOmics data generation
CRISPR experiment Drug screening PK/PD experiment Tox screening |
Research Theme
